Development, validation and implementation of a receptor based bioassay capable of detecting a broad range of beta-agonist drugs in animal feedingstuffs.
A bioassay was developed for the detection of a broad range of beta-agonist compounds in animal feeds. A solubilised beta2-adrenoceptor was utilised as the binding protein in the assay. This protein was found to be highly stable when stored at 80 degrees C. The assay was developed and initially validated to determine the sensitivity and relative selectivity against a panel of commonly used beta-agonist compounds. It was also shown that when beta-agonists were present as cocktails in samples a pronounced synergistic effect could be measured. The method was further validated according to EC Decision 2002/657 and proved capable of detecting 250ng clenbuterol equivalents per gram of sample. This is well below the quantities normally associated with beta-agonist medicated feeds. The beta2-adrenoceptor used in the study only failed to bind the compound zilpaterol, raising doubts as to whether this compound is a true beta2-adrenergic drug.
Boyd
S
S
Food Standards Agency for Northern Ireland, 10 A-C Clarendon Road Belfast, BT1 3BG, Northern Ireland.
Heskamp
H H
HH
Bovee
T F H
TF
Nielen
M W F
MW
Elliott
C T
CT
D000318:Adrenergic beta-Agonists / Q000032:analysis*; D000821:Animal Feed; D000818:Animals; D001681:Biological Assay / Q000379:methods*; D007753:Laboratories / Q000592:standards; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism; D015203:Reproducibility of Results
D000318:Adrenergic beta-Agonists; D018343:Receptors, Adrenergic, beta-2